Four Digital Saviors Of Indian Pharma During COVID-19
BY VIBHA RAVI Executive Summary From digital marketing to payment systems, electronic solutions are aiding Indian pharma to ensure business continuity during the lockdown. New guidelines are spurring the adoption of telemedicine. Digital tools are connecting companies to their distribution chains and health care professionals. While some changes are here to stay, others might not stick.
26 / September 2020
As private clinics shut down across India, patients could not get to health care facilities due to strict restrictions on movements and hospitals were hit by a government-mandated cessation of elective procedures as well as incidences of COVID-19 among staff. The pharmaceutical industry has witnessed an unprecedented crisis during the pandemic-led lock-down in the country. Acute and sub-chronic segments saw a sharp dip in sales while the chronic segment also suffered. A report on the impact of COVID-19 on the practice of health care professionals (HCPs) by Cognitrex Consultants and SIHMRACI Educations Pvt. Ltd. showed gynecologists saw a 40% decline in their patient base, while plastic surgeons saw a 90% fall. An initial assessment by IQVIA estimates that growth in the Indian pharmaceutical market could slide to 1-5% in 2020 from earlier
Š Informa UK Ltd 2020 (Unauthorized photocopying prohibited.)
